Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles....
Elektrobit and global partner to jointly develop EV.OS - an AI-centric automotive platform for software-defined vehicles
AI-centric, smart automotive platform will accelerate the transition towards software-defined mobility. ERLANGEN, Germany, June 25, 2025 /PRNewswire/ -- Elektrobit today announced the signing of a joint development agreement (JDA) with Hon Hai...
NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test
SEOUL, South Korea, Feb. 21, 2025 /PRNewswire/ -- PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered healthcare solutions. NAVER D2SF, NAVER's corporate venturing arm, actively collaborates with startups to drive innovation...
NAVER D2SF Invests in "STUDIO LAB," an AI-Powered E-Commerce Content Generation Startup
Leveraging multimodal AI to create high-quality product detail pages for e-commerce—completing texts, images, and layouts in 15–30 seconds Secured partnerships with over 30 fashion companies and platforms, expanding into the North American and...
